Ethics, FDA & Patient–Provider Interaction (PPI) with AI
A practical, clinician‑first playbook to deploy AI responsibly: ethics foundations, FDA concepts to watch, and patient–provider interaction (PPI) patterns that preserve trust, autonomy, and safety.
1) Ethical Foundations
- Beneficence & Non‑maleficence: AI must show net clinical benefit and avoid foreseeable harm.
- Autonomy: Patients should understand when and how AI influences their care and be free to opt out where feasible.
- Justice: Evaluate for disparate performance across demographics; mitigate inequality in access and outcomes.
- Accountability: Keep a clear line of human responsibility for decisions, overrides, and escalation.
2) FDA Concepts to Track (U.S.)
This is a high‑level orientation for planning; it is not legal or regulatory advice.
- SaMD framing: When software performs a medical function, it may fall under Software as a Medical Device considerations.
- Predetermined Change Control Plans (PCCP): Outline what you intend to update post‑market (e.g., model retraining) and how you’ll manage risk.
- Good ML Practices: Emphasize data quality, reproducibility, transparency, and robust evaluation.
- Post‑market surveillance: Monitor performance, usability, failures, and complaints; be ready to act.
3) Patient–Provider Interaction (PPI) Patterns
Transparent AI Use
“An AI tool helped summarize your chart and suggest next steps. Your clinician reviews and decides what to do.”
Consent & Choice
Offer explanations and alternatives (human‑only review, second opinions) when reasonable.
Explainability
Provide rationale snippets, confidence ranges, and uncertainty flags; avoid false certainty.
Escalation
Set clear triggers for human review and specialist consults when AI outputs conflict or are low‑confidence.
4) Operational Guardrails
- Document permitted and prohibited use‑cases; keep a living registry of models and versions.
- Bias & performance checks pre‑deployment and on a recurring schedule; publish a model factsheet.
- Real‑time monitoring of drift, alert fatigue, override rates, and adverse events.
- Security & privacy controls aligned to institutional policy and law; least‑privilege access.
- Incident response playbook for model outages, misbehavior, and data issues.
5) Documentation Set (Minimum)
- Clinical intent statement and decision pathway diagrams.
- Data lineage & quality report; training/validation cohorts.
- Validation metrics (sensitivity/specificity/PPV/NPV), subgroup analysis, and known limitations.
- User‑facing disclosures, consent language, and risk statements.
- Monitoring KPIs and governance roles with escalation contacts.
Quick Start: 12‑Point Readiness Scan
Resumen en Español (breve)
Guía práctica para IA clínica centrada en el paciente: fundamentos éticos (beneficencia, autonomía, justicia), ideas clave para FDA (SaMD, PCCP, buenas prácticas de ML, vigilancia pos‑mercado), patrones de interacción paciente‑profesional (transparencia, consentimiento, explicabilidad, escalado), guardas operativas y un set mínimo de documentación para gobernanza y cumplimiento.
Educational content only — not legal, medical, or regulatory advice. Adapte esta información a su jurisdicción y protocolos.